Who is sponsoring NCT00367978?

NCT00367978 is sponsored by Novartis.

What condition does NCT00367978 study?

NCT00367978 studies Hypertension.

What drugs are being tested in NCT00367978?

Interventions: Amlodipine/benazepril.

What is the status of NCT00367978?

NCT00367978 is currently COMPLETED.

Last reviewed 2011-11-07 · How we verify

A Randomized, Multicenter, Study to Determine the Efficacy and Safety of Amlodipine/Benazepril Hydrochloride Versus Enalapril in the Treatment of Hypertension in an African-American Population With Type 2 Diabetes

NCT00367978 Phase 4 COMPLETED

This study evaluated the efficacy and safety of amlodipine/benazepril compared with that of enalapril in the treatment of hypertension in African-American patients with type 2 diabetes.

Details

Lead sponsor	Novartis
Phase	Phase 4
Status	COMPLETED
Enrolment	275
Start date	2001-12
Completion	2003-09

Conditions

Hypertension

Interventions

Amlodipine/benazepril

Primary outcomes

Time from baseline to the achievement of first treatment success (defined as achieving a blood pressure (BP) <130/80 mm Hg). The proportion and cumulative proportion of patients who achieved first treatment success were also determined.

Countries

United States